Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06636825 · ClinicalTrials.gov registry record · NA
Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia
A NA study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT06636825 is a NA study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 29 participants.
The verdict
NCT06636825, a NA study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The aim of this randomized, double-blind, placebo-controlled crossover trial is to determine the effects of caffeine vs. placebo on psychomotor vigilance and carbon dioxide tolerance during graded hypercapnia.
Interventions
- DRUG Placebo
- DRUG Caffeine
- OTHER Graded hypercapnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-11-09 |
| Est. Completion | 2024-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06636825
The ClinicalTrials.gov registry entry for NCT06636825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06636825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06636825 about?
NCT06636825 is a clinical study titled "Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia". The aim of this randomized, double-blind, placebo-controlled crossover trial is to determine the effects of caffeine vs. placebo on psychomotor vigilance and carbon dioxide tolerance during graded hypercapnia.
What is the current status of trial NCT06636825?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-11-09. Estimated completion is 2024-09-17.
What interventions are being tested in trial NCT06636825?
The interventions under investigation include: Placebo (DRUG), Caffeine (DRUG), Graded hypercapnia (OTHER).
Who is sponsoring clinical trial NCT06636825?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.